Pronađeno: 1-8 / 8 radova

Autori: Ceric Timur

>> Filter: Samo Article i Review

Naslov Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers (Article)
Autori Miletic Dragana  Kraljevic Marija  Sokolovic Emir  Soce Majana  Milovic-Kovacevic Marijana M  Bobic Simonida  Ceric Timur  Plestina Stjepko  Beslija Semir  Marijanovic Inga 
Info MEDICAL SCIENCE MONITOR, (2023), vol. 29 br. , str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov A phase Ib/II study of the dual MDMX/MDM2 inhibitor, ALRN-6924, for the prevention of chemotherapy-induced myelosuppression (Meeting Abstract)
Autori Andric Zoran G  Ceric Timur  Rancic Milan H  Jakopovic Marko  Aix S Ponce  Ramlau Rodryg  Ulanska M  Caldwell C  Ferrari D  Annis A  Vukovic V  Zaric Bojan 
Info ANNALS OF ONCOLOGY, (2021), vol. 32 br. , Suppl. 5, str. S1166-S1166
Projekat Aileron Therapeutics Inc.
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Prevention of Chemotherapy-induced Myelosuppression in SCLC patients treated with the Dual MDMX/MDM2 Inhibitor ALRN-6924 (Meeting Abstract)
Autori Andric Zoran G  Ceric Timur  Stanetic Mirko  Rancic Milan H  Jakopovic Marko  Aix S Ponce  Ramlau Rodryg  Smit E  Ulanska M  Caldwell C  Ferrari D  Annis A  Vukovic V  Zaric Bojan 
Info EUROPEAN JOURNAL OF CANCER, (2020), vol. 138 br. , Suppl. 2, str. S5-S5
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan) (Article)
Autori Todorovic Vladimir  ...  Babovic Nada Lj  ...  Cetnikovic Bojana  Ceric Timur  ...  Dzamic Zoran M  Dzodic Radan R  Eri Zivka  ...  Knezevic-Usaj Slavica F  Kovcin Vladimir N  ...  Markovic Ivan Z  Markovic Milan  Mijalkovic Nenad  ...  Pantelic Aleksandra  Popovic Lazar S  Radosavljevic Davorin Z  ...  Radulovic Sinisa S  ...  Rosic Ivana  ...  Stamatovic Ljiljana  ...  Tesanovic Dusanka D  Tomasevic Zorica I  Tomasevic Zoran M  ...  Vasovic Suzana  Vicko Ferenc  ...  Zaric Bojan  ...  (broj koautora 65) 
Info JOURNAL OF BUON, (2019), vol. 24 br. 5, str. 2180-2197
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Galaxy-2 trial (NCT01798485): A randomized phase 3 study of ganetespib itt combination with docetaxel versus docetaxel alone in patients with advanced lung adenocarcinoma. (Meeting Abstract)
Autori Ramalingam Suresh S  Zaric Bojan  Ceric Timur  ...  Samarzija Miroslav  ...  Vukovic Vojislav M  (broj koautora 20) 
Info JOURNAL OF CLINICAL ONCOLOGY, (2014), vol. 32 br. 15, Suppl. S, str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov A randomized study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel versus docetaxel alone for second-line therapy of lung adenocarcinoma (GALAXY-1) (Meeting Abstract)
Autori Ramalingam Suresh S  ...  Andric Zoran G  ...  Zaric Bojan  Ceric Timur  ...  Vukovic Vojislav M  ...  (broj koautora 20) 
Info JOURNAL OF CLINICAL ONCOLOGY, (2013), vol. 31 br. 15, Suppl. S, str. -
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Ganetespib in combination with docetaxel versus docetaxel alone in second line adenocarcinoma patients with KRAS mutations and elevated LDH levels (Meeting Abstract)
Autori Fennell DA  Goss GD  Andric Zoran G  Bondarenko Igor N  Zaric Bojan  Ceric Timur  Poddubskaya Elena  Teofilovici F  Guo W  Ramalingam Suresh S 
Info EUROPEAN JOURNAL OF CANCER, (2013), vol. 49 br. , Suppl. 2, str. S801-S801
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Quality of Life Analysis in the Galaxy Trialtm (Nct01348126): a Randomized Phase Iib/Iii Study of Ganetespib (Sta-9090) in Combination with Docetaxel Versus Docetaxel Alone in Patients with Stage Iiib Or Iv Nsclc (Meeting Abstract)
Autori Andric Zoran G  Havel L  Di Hariry I  Vukovic Vojislav M  Teofilovici F  Guo W  Mulcahey S  Bradley R  Ceric Timur 
Info ANNALS OF ONCOLOGY, (2012), vol. 23 br. , Suppl. 9, str. 436-436
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX